Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06788756 |
| Consolidated Lead Sponsor | Moleculin Biotech |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II/III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 312 participants (ESTIMATED) |
| Registered Start Date | 2025-03-12 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Nebraska Medical Center | Omaha, NE | Open Hospital Dossier -> |
| University Hospitals Cleveland Medical Center | Cleveland, OH | Open Hospital Dossier -> |
| University of Pennsylvania Abramson Cancer Center | Philadelphia, PA | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.